Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study

BACKGROUND/AIMS: Crohn’s disease is a chronic disorder; therefore, it is essential to investigate long-term safety and efficacy of treatments. This study assessed the safety and effectiveness of adalimumab for up to 3 years in Japanese patients with Crohn’s disease in real-world settings. METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Hisamatsu, Tadakazu, Suzuki, Yasuo, Kobayashi, Mariko, Hagiwara, Takashi, Kawaberi, Takeshi, Ogata, Haruhiko, Matsui, Toshiyuki, Watanabe, Mamoru, Hibi, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566837/
https://www.ncbi.nlm.nih.gov/pubmed/33207857
http://dx.doi.org/10.5217/ir.2020.00025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566837/
https://www.ncbi.nlm.nih.gov/pubmed/33207857
http://dx.doi.org/10.5217/ir.2020.00025

Ejemplares similares